Annual Report

The report describes Chugai's 2011 performance amid disruptions from the Great East Japan Earthquake, with revenues of ¥373,517 million. It highlights a growing personalized-healthcare pipeline, including 12 drug candidates and nine additional projects in biomarker discovery. The company also details its disaster response, including donations to relief efforts and support for medical care in affected areas.